← brief for 2026-10-19 · Slowing decline
Glucagon-Like Peptide-1 Receptor Agonists and Multi-hormone Receptor Modulators for Kidney Protection in Nondiabetic Kidney Disease.
Key takeaways
This review explains how certain diabetes drugs might protect the kidneys. It looks at people who do not have diabetes. It summarizes what is known about how these drugs work. There are no new trial results in this piece, just a summary of existing science and mechanisms.
Who did this work
Pasricha SV · Faruque LI · Mohsen M · Brown TD · Yau K · Medak KD · Cherney DZI · Muskiet MHA · Odutayo A
Source
Article · PubMed, the drug frontier · 2026 Oct 19
https://pubmed.ncbi.nlm.nih.gov/42895792/